Author: Leigh MacMillan
Study details metabolism of biomarkers for oxidative stress
Mar. 7, 2024—A Vanderbilt study demonstrates that factors other than oxidative stress can modify F2-IsoP levels.
Multi-institutional study of Wilms tumor facilitates enrollment, optimizes treatment
Feb. 27, 2024—Multi-institutional study finds that enrollment and outcomes were similar across racial and ethnic groups for children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide.
Large, diverse genetic study of glaucoma implicates vascular and cancer-related genes
Feb. 21, 2024—An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.
Liver disease specialist Spann receives two career development awards
Feb. 20, 2024—Vanderbilt's Ashley Spann, MD, MSACI, is the inaugural recipient of the Harold Amos Medical Faculty Development Program Hepatology Award from the American Association for the Study of Liver Diseases.
Humphries receives John V. Bergen Excellence Award
Feb. 1, 2024—Vanderbilt's Romney Humphries, PhD, has received the 2024 John V. Bergen Excellence Award from the Clinical and Laboratory Standards Institute.
Expanded space boosts cutting-edge research in infectious diseases and immunology
Jan. 29, 2024—The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.
Harvard immunologist Springer next up in Discovery Lecture Series
Jan. 29, 2024—Harvard's Timothy Springer, PhD, a world leader in structural biology and immunology, will deliver the next Discovery Lecture at Vanderbilt on Thursday, Feb. 8.
Hartmann named director of UK Center for Clinical and Translational Science
Jan. 17, 2024—Katherine Hartmann, MD, PhD, Vice President for Research Integration for Vanderbilt University Medical Center, has been named director of the University of Kentucky (UK) Center for Clinical and Translational Science.
‘Molecular Muse’ exhibit features Artist-in-Residence program’s science-inspired art
Jan. 16, 2024—The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool.
Glucose metabolism influences B cell function
Dec. 29, 2023—Glucose metabolism influences the qualities of activated, mature B cells — white blood cells that are required for antibody-mediated immune responses, Vanderbilt researchers discovered.
Gut microbiota metabolite protects against obesity: study
Dec. 8, 2023—Vanderbilt researchers have discovered that beneficial bacteria in the small intestines produce a compound that protects against obesity.
Pasteurization reduces bioactive component of breast milk
Dec. 6, 2023—Pasteurization of breast milk affects the concentration of osteopontin, a bioactive protein with roles in intestinal, immunological and brain development — suggesting that osteopontin supplementation should be considered when donor milk is provided to preterm infants.